During the last 5 years progress in molecular genetics has offered the poss
ibility of genetic testing for inherited mutations of cancer-predisposing g
enes. The exact cellular function and carcinogenic potential of these genes
is yet not completely understood. Only in 5-20% of all cancers inherited g
enetic mutations play an important role in the polygenic and multifactorial
nature of the disease. Identification of inherited cancer syndromes, predi
ctive genetic testing, and counselling of women and family members at incre
ased risk is of clinical importance. The debate surrounding presymptomatic
diagnostic testing and adequate programmes for early cancer detection, prev
ention or clinical follow-up continues.